These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4007054)

  • 1. Antifibrillatory properties of alinidine after coronary artery occlusion in rats.
    Harron DW; Brezina M; Lillie C; Kobinger W
    Eur J Pharmacol; 1985 Apr; 110(3):301-8. PubMed ID: 4007054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of HNS-32, a novel antiarrhythmic drug, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats.
    Saitoh M; Aye NN; Komori S; Nakazawa T; Hashimoto K
    Mol Cell Biochem; 2000 Feb; 205(1-2):133-40. PubMed ID: 10821431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing.
    Uprichard AC; Chi LG; Lynch JJ; Driscoll EM; Frye JW; Lucchesi BR
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):475-82. PubMed ID: 2476629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in systemic haemodynamics, regional myocardial function and perfusion induced by alinidine in pigs with and without narrowed coronary arteries.
    Verdouw PD; Duncker DJ; Heere TJ; Saxena PR
    Eur Heart J; 1987 Dec; 8 Suppl L():43-52. PubMed ID: 3451882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alinidine on experimental cardiac arrhythmias.
    Harron DW; Allen JD; Wilson R; Shanks RG
    J Cardiovasc Pharmacol; 1982; 4(2):221-5. PubMed ID: 6175804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alinidine on survival and infarct size in rats with coronary artery occlusion.
    Reichhalter R; Lillie C; Kobinger W
    Eur J Pharmacol; 1988 Nov; 157(1):75-81. PubMed ID: 3234496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the 'specific bradycardic agent' alinidine on the function of ischemic myocardium.
    Schad H; Heimisch W; Haas F; Mendler N
    Thorac Cardiovasc Surg; 1991 Dec; 39 Suppl 3():211-6. PubMed ID: 1803632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine.
    Komori S; Sawanobori T; Tamura K; Kane KA; Parratt JR
    Jpn J Pharmacol; 1994 Jul; 65(3):193-200. PubMed ID: 7799519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence.
    Heidbüchel H; Tack J; Vanneste L; Ballet A; Ector H; Van de Werf F
    Circulation; 1994 Mar; 89(3):1051-9. PubMed ID: 8124790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bidisomide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide.
    Komori S; Sano S; Li BH; Matsumura K; Naitoh A; Mochizuki S; Ishihara T; Watanabe A; Umetani K; Ijiri H
    Heart Vessels; 1995; 10(1):7-11. PubMed ID: 7537263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic and antifibrillatory action of diltiazem on early and late phase ventricular arrhythmias following coronary artery occlusion and on reperfusion ventricular arrhythmias.
    Thale J; Gülker H; Olbing B; Rose D; Bender F
    Pharmacology; 1986; 33(1):1-13. PubMed ID: 3737671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary occlusion before, during, and after strenuous exercise.
    Thompson PL; Lown B
    Cardiovasc Res; 1976 May; 10(3):385-8. PubMed ID: 954022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alinidine on metabolic response to high-demand myocardial ischemia.
    Hanet C; Pouleur H; Hue L; Caucheteux D; Gurné O; Maldague P; Rousseau MF
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):405-11. PubMed ID: 2471886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alinidine in multi-vessel coronary disease: reduction of stress-induced ischemic reaction].
    Ditter H; Müller KD; Bahavar H; Schlepper M
    Z Kardiol; 1991 Feb; 80(2):167-70. PubMed ID: 2058248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of alinidine, an N-allyl derivative of clonidine, on regional myocardial perfusion and performance in the pig with or without atrial pacing.
    Verdouw PD; Saxena PR; Schamhardt HC; van der Hoek TM; Rutteman AM
    Eur J Pharmacol; 1980 Jun; 64(4):209-20. PubMed ID: 7389819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
    Beatch GN; Abraham S; MacLeod BA; Yoshida NR; Walker MJ
    Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
    Sun W; Wainwright CL
    Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
    Manning AS; Bruyninckx C; Ramboux J; Chatelain P
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):453-61. PubMed ID: 8583788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac electrophysiologic effects of alinidine, a specific bradycardic agent, in the conscious dog: plasma concentration-response relations.
    Boucher M; Chassaing C; Chapuy E
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):229-33. PubMed ID: 7752648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion.
    Aidonidis I; Brachmann J; Rizos I; Zacharoulis A; Stavridis I; Toutouzas P; Kübler W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):555-63. PubMed ID: 8547205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.